Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Much Is the Global Advanced Therapy Medicinal Products Market Valued at Present and by 2029?
The market size for advanced therapy medicinal products has seen accelerated growth in recent years. The market is anticipated to expand from $42.85 billion in 2024 to $51.34 billion in 2025, showcasing a compound annual growth rate (CAGR) of 19.8%. Factors contributing to this stellar growth in the historical period include the escalating number of clinical trials for gene and cell therapies, a rise in rare and genetic disorders, an increase in the demand for therapeutic treatments instead of managing chronic diseases, a higher success rate of early-stage clinical research, along with the growing occurrence of chronic and age-related ailments.
In the coming years, it is anticipated that the market size for advanced therapy medicinal products will experience substantial growth. By 2029, it’s predicted that the market value will reach $104.43 billion following a compound annual growth rate (CAGR) of 19.4%. Factors contributing to the projected growth during the forecasted period include increased interest in tailored and precision medicinal approaches, a growing pipeline of chimeric antigen receptor t-cell and gene-editing therapies, higher uptake of precision medicine and genomics, increased healthcare spending in developing markets, and a heightened focus on decentralized clinical trial models. Main trends forecasted for this period comprise the advancement of allogeneic off-the-shelf therapies, the development of non-viral gene delivery vectors, integrating digital twins in therapy simulation, utilizing blockchain in supply chain tracking, and implementing 3D bioprinting techniques for tissue engineering.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25689&type=smp
#What Drivers Are Influencing Growth In The Advanced Therapy Medicinal Products Market?
The burgeoning interest in customized medical treatments is anticipated to stimulate the expansion of the advanced therapy medicinal products market. Customized medical treatments imply a healthcare approach that personalized prevention and treatment strategies, based on a person’s distinctive genetic composition, lifestyle, and surroundings. The growing appeal for these treatments is primarily resultant from the increasing incidence of persistent illnesses, as these allow for treatment modifications which enhance results and diminish side effects for specific patients. Advanced therapy medicinal products facilitate customized treatments by providing genetically modified, cell, and tissue developed therapies that target the individual genetic and biological profiles of patients. According to a report by the Personalized Medicine Coalition, a non-profit organization based in the US, in February 2024, the FDA approved 16 new customized treatments for individuals with rare diseases in 2023, a significant increase from just six in 2022. This also included seven treatments for cancer and three for other diseases and conditions during 2023. Consequently, the escalating demand for customized medical treatments is steering the growth of the advanced therapy medicinal products market.
What Are The Main Segments Identified In The Advanced Therapy Medicinal Products Market Research?
The advanced therapy medicinal products market covered in this report is segmented –
1) By Product: Somatic Cell Therapy Medicinal Products, Tissue Engineered Medicinal Products, Gene Therapy Medicinal Products
2) By Technology: Gene Editing Technologies, Viral Vector Technology, Stem Cell Technology, Automation And Artificial Intelligence-Driven Processes
3) By Application: Muscular Dystrophies, Alzheimer’s, Hemophilia, Cystic Fibrosis, Other Applications
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
5) By End User: Hospitals, Specialty Clinics, Other End Users
Subsegments:
1) By Somatic Cell Therapy Medicinal Products: Autologous Cell Therapy, Allogeneic Cell Therapy, Stem Cell Therapy, Dendritic Cell Therapy, Natural Killer Cell Therapy
2) By Tissue Engineered Medicinal Products: Autologous Tissue-Engineered Products, Allogeneic Tissue-Engineered Products, Scaffold-Based Tissue Engineering, Scaffold-Free Tissue Engineering, Skin Substitutes
3) By Gene Therapy Medicinal Products: In Vivo Gene Therapy, Ex Vivo Gene Therapy, Viral Vector-Based Gene Therapy, Non-Viral Vector-Based Gene Therapy, Gene Editing Therapies
What Are The Leading Trends And Opportunities In The Advanced Therapy Medicinal Products Sector?
Major corporations in the market for advanced therapy medicinal products are directing their efforts towards the development of innovative therapies, such as novel car-t cell therapies, to enhance the results of treatments for cancer and other severe diseases. Car-t cell therapies are an advanced form of cancer treatment that uses the patient’s own T cells, which are genetically modified to identify and eliminate cancer cells. An example of this is Novartis AG, a pharmaceutical company based in Switzerland. They secured approval from the U.S. Food and Drug Administration (FDA) in May 2022 for Kymriah, a CAR-T cell therapy created to treat patients with recurrent or resistant follicular lymphoma (FL) who have undergone at least two previous systemic treatments. This therapy employs the patient’s own T cells, genetically programmed to carry a chimeric antigen receptor (CAR) that targets the cd19 protein. This alteration allows the T cells to identify and annihilate malignant B cells. Kymriah has the added feature of a 4-1BB costimulatory domain which boosts T cell development and continuance, thereby producing sustained anti-tumor impacts from a single infusion.
Which Companies Play A Key Role In The Development Of The Advanced Therapy Medicinal Products Market?
Major companies operating in the advanced therapy medicinal products market are F. Hoffmann-La Roche Limited., Novartis AG, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited., Lonza Group AG, Catalent Inc., BioMarin Pharmaceutical Inc., AGC Biologics Inc., ViaCyte Inc., Rentschler Biopharma SE, JCR Pharmaceuticals Co. Ltd., Vericel Corporation, UniQure N.V., Fate Therapeutics Inc., WuXi Advanced Therapies Inc., Celonic Group AG, Pharmicell Co. Ltd., Magenta Therapeutics Inc, MEDIPOST Co. Ltd., Kolon TissueGene Inc
Get The Full Report Here:
What Are The Key Regional Developments Shaping The Advanced Therapy Medicinal Products Market?
North America was the largest region in the advanced therapy medicinal products market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the advanced therapy medicinal products market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=25689&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
